CAPS Medical is a health-tech startup that operates in the oncology sector, specifically focusing on the treatment of non-muscle invasive bladder cancer (NMIBC). The company has developed a unique solution that uses NTAP (Non-Thermal Atmospheric Plasma) to selectively destroy cancer cells without causing harm to surrounding healthy tissues. This innovative approach is designed to overcome the challenges of delivering NTAP to internal organs, a task that has historically been difficult.

The company's primary market is the United States, where there are approximately 500,000 sufferers of NMIBC, with an additional 80,000 new patients diagnosed annually. However, with 19.3 million new cancer cases worldwide each year, the potential global market for CAPS Medical's solution is significant.

CAPS Medical's business model revolves around the use of a disposable catheter, which is delivered through the working channel of standard minimally invasive tools. This keyhole procedure does not require a tissue incision, which means there is no bleeding or scarring. The treatment is highly consistent, thanks to the use of real-time energy monitoring.

The company generates revenue by selling these disposable catheters to healthcare providers. In the future, CAPS Medical plans to expand its solution to other types of cancer, including lung, liver, breast, and gastrointestinal cancers, among others.

In summary, CAPS Medical is a promising startup in the oncology sector, offering a unique and innovative solution to cancer treatment that has the potential to significantly improve patient prognosis by preserving healthy tissue.

Keywords: CAPS Medical, health-tech startup, oncology, non-muscle invasive bladder cancer, NTAP, minimally invasive, disposable catheter, real-time energy monitoring, patient prognosis, cancer treatment.